Elekta AB Gross Margin 2013-2026 | EKTAY
Current and historical gross margin for Elekta AB (EKTAY) over the last 10 years. The current gross profit margin for Elekta AB as of January 31, 2026 is %.
| Elekta AB Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-01-31 | $1.77B | $0.66B | 37.48% |
| 2025-10-31 | $1.74B | $0.66B | 37.99% |
| 2025-07-31 | $1.73B | $0.65B | 37.44% |
| 2025-04-30 | $1.71B | $0.64B | 37.47% |
| 2025-01-31 | $1.68B | $0.61B | 36.42% |
| 2024-10-31 | $1.69B | $0.62B | 36.35% |
| 2024-07-31 | $1.70B | $0.62B | 36.38% |
| 2024-04-30 | $1.71B | $0.64B | 37.36% |
| 2024-01-31 | $1.72B | $0.65B | 37.71% |
| 2023-10-31 | $1.70B | $0.65B | 38.08% |
| 2023-07-31 | $1.65B | $0.63B | 38.27% |
| 2023-04-30 | $1.61B | $0.61B | 37.67% |
| 2023-01-31 | $1.58B | $0.59B | 37.54% |
| 2022-10-31 | $1.56B | $0.58B | 37.20% |
| 2022-07-31 | $1.61B | $0.61B | 37.80% |
| 2022-04-30 | $1.64B | $0.61B | 37.42% |
| 2022-01-31 | $1.61B | $0.61B | 37.93% |
| 2021-10-31 | $1.64B | $0.63B | 38.42% |
| 2021-07-31 | $1.61B | $0.63B | 38.96% |
| 2021-04-30 | $1.58B | $0.64B | 40.76% |
| 2021-01-31 | $1.56B | $0.65B | 41.74% |
| 2020-10-31 | $1.51B | $0.65B | 42.60% |
| 2020-07-31 | $1.49B | $0.64B | 42.70% |
| 2020-04-30 | $1.52B | $0.64B | 42.02% |
| 2020-01-31 | $1.55B | $0.66B | 42.81% |
| 2019-10-31 | $1.54B | $0.65B | 42.54% |
| 2019-07-31 | $1.52B | $0.65B | 42.64% |
| 2019-04-30 | $1.50B | $0.63B | 41.88% |
| 2019-01-31 | $1.49B | $0.61B | 40.72% |
| 2018-10-31 | $1.46B | $0.60B | 40.97% |
| 2018-07-31 | $1.43B | $0.59B | 41.14% |
| 2018-04-30 | $1.37B | $0.57B | 41.87% |
| 2018-01-31 | $1.35B | $0.57B | 42.17% |
| 2017-10-31 | $1.32B | $0.55B | 41.72% |
| 2017-07-31 | $1.25B | $0.52B | 41.66% |
| 2017-04-30 | $1.23B | $0.51B | 41.31% |
| 2017-01-31 | $1.23B | $0.51B | 41.41% |
| 2016-10-31 | $1.24B | $0.51B | 41.39% |
| 2016-07-31 | $1.29B | $0.53B | 41.32% |
| 2016-04-30 | $1.33B | $0.55B | 41.14% |
| 2016-01-31 | $1.35B | $0.54B | 39.84% |
| 2015-10-31 | $1.36B | $0.53B | 38.59% |
| 2015-07-31 | $1.37B | $0.52B | 37.95% |
| 2015-04-30 | $1.37B | $0.50B | 36.03% |
| 2015-01-31 | $1.49B | $0.57B | 38.02% |
| 2014-10-31 | $1.55B | $0.61B | 39.11% |
| 2014-07-31 | $1.58B | $0.63B | 40.03% |
| 2014-04-30 | $1.60B | $0.67B | 42.10% |
| 2014-01-31 | $1.59B | $0.70B | 43.73% |
| 2013-10-31 | $1.60B | $0.72B | 44.96% |
| 2013-07-31 | $1.60B | $0.73B | 45.81% |
| 2013-04-30 | $1.55B | $0.72B | 46.19% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.226B | $1.708B |
| Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.365B | 21.69 |
| Intuitive Surgical (ISRG) | United States | $160.029B | 61.73 |
| Edwards Lifesciences (EW) | United States | $44.895B | 30.42 |
| IDEXX Laboratories (IDXX) | United States | $44.716B | 43.08 |
| Alcon (ALC) | Switzerland | $38.585B | 25.49 |
| Waters (WAT) | United States | $31.413B | 24.37 |
| IQVIA Holdings (IQV) | United States | $28.398B | 15.40 |
| Mettler-Toledo (MTD) | United States | $26.829B | 30.97 |
| DexCom (DXCM) | United States | $24.639B | 30.63 |
| STERIS (STE) | Ireland | $21.830B | 22.08 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $15.055B | 23.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $13.774B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.199B | 9.72 |
| Penumbra (PEN) | United States | $12.941B | 85.88 |
| Globus Medical (GMED) | United States | $12.230B | 22.60 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| Glaukos (GKOS) | United States | $6.760B | 0.00 |
| SARTORIUS (SSSGY) | Germany | $6.754B | 39.22 |
| Sysmex ADR (SSMXY) | Japan | $5.470B | 18.10 |
| Teleflex (TFX) | United States | $5.233B | 9.67 |
| TransMedics (TMDX) | United States | $3.910B | 40.00 |
| LivaNova (LIVN) | United Kingdom | $3.433B | 18.41 |
| Integer Holdings (ITGR) | United States | $2.900B | 13.28 |
| Veracyte (VCYT) | United States | $2.470B | 24.48 |
| Artivion (AORT) | United States | $1.825B | 59.73 |
| AxoGen (AXGN) | United States | $1.659B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.650B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.642B | 18.12 |
| UFP Technologies (UFPT) | United States | $1.552B | 20.54 |
| Tandem Diabetes Care (TNDM) | United States | $1.314B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.308B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.269B | 0.00 |
| IRadimed (IRMD) | United States | $1.194B | 53.37 |
| OPKO Health (OPK) | United States | $0.881B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.772B | 4.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 15.09 |
| Alpha Tau Medical (DRTS) | Israel | $0.618B | 0.00 |
| SiBone (SIBN) | United States | $0.567B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.552B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.533B | 28.23 |
| Mesa Laboratories (MLAB) | United States | $0.530B | 13.79 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.497B | 0.00 |
| NeuroPace (NPCE) | United States | $0.480B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.405B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.405B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.404B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.393B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.346B | 143.43 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.296B | 0.00 |
| RxSight (RXST) | United States | $0.282B | 0.00 |
| 908 Devices (MASS) | United States | $0.267B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.257B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.203B | 0.00 |
| CVRx (CVRX) | United States | $0.188B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.186B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.148B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.119B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.117B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.111B | 0.00 |
| Solana (HSDT) | United States | $0.104B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.096B | 0.00 |
| Neuronetics (STIM) | United States | $0.094B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 0.00 |
| LENSAR (LNSR) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | United States | $0.060B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| DarioHealth (DRIO) | United States | $0.053B | 0.00 |
| Envoy Medical (COCH) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.047B | 0.00 | |
| Accuray (ARAY) | United States | $0.046B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.028B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| NexGel (NXGL) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |